Human herpes virus 6 antibodies in beta-thalassemia/hemoglobin E pediatric patients

Area of Science:

• Virology
• Pediatric Hematology
• Infectious Diseases

Background:

• Human herpesvirus 6 (HHV-6) is a common viral pathogen.
• HHV-6 causes exanthem subitum in children and severe illness in immunocompromised individuals.
• Beta-thalassemia/HbE disease impacts pediatric patients, potentially affecting their immune status.

Purpose of the Study:

• To investigate the seroprevalence of HHV-6 infection in pediatric patients with beta-thalassemia/HbE disease.
• To assess HHV-6 IgM and IgG antibody levels in this patient cohort.
• To evaluate potential correlations between HHV-6 infection and disease status, including splenectomy.

Main Methods:

• Serological study involving 29 children (12 female, 17 male) diagnosed with beta-thalassemia/HbE.
• Detection and quantification of HHV-6 specific IgM and IgG antibodies.
• Comparison of antibody titers between splenectomized and non-splenectomized patients.

Main Results:

• A high overall HHV-6 infection rate of 86.2% was observed.
• Rates included 13.8% early recent infection (IgM+), 41.4% recent infection (IgM+/IgG+), and 31.0% past infection (IgG+).
• Geometric mean titers for IgM and IgG were comparable between splenectomy and non-splenectomy groups, though IgG titers were slightly higher in the non-splenectomy group.

Conclusions:

• Pediatric patients with beta-thalassemia/HbE disease exhibit a very high prevalence of HHV-6 infection.
• Elevated HHV-6 antibody titers in this population may indicate an increased risk for complications, potentially including bone marrow transplantation.
• Enhanced awareness and monitoring of HHV-6 infections are crucial for managing pediatric patients with beta-thalassemia/HbE disease.